Close Window

Digital Look Email A Friend

Actavis hiked price of hormone replacement drug 12,000%, says CMA

Published by Maryam Cockar on 16th December 2016

(ShareCast News) - A regulatory body has accused pharmaceutical Actavis UK of breaking competition law by hiking the price of a hormone replacement drug by 12,000% to the NHS.

URL: http://www.digitallook.com/dl/news/story/25342818/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.